The cybersecurity company’s so-so earnings were weighing on shares, but analysts remain upbeat about its platformization push ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Bio-Rad Laboratories' cost-cutting plans come as the company swung to a loss in the fourth quarter amid lower sales across its life-science segment. The company posted a net loss of $715.8 million, or ...

A gauge of the U.S. equities that equally weights stocks in the S&P 500 index was clinging to a slight gain on Friday afternoon. The Invesco S&P 500 Equal Weight ETF was up 0.1% in afternoon trading, ...

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

DaVita Inc.'s stock was tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway Inc. pared its stake in the provider of kidney dialysis.

Informatica stock tumbled on Friday after the data management platform issued soft first-quarter and full-year guidance, and ...

Builders have increasingly relied on buyer incentives to mitigate the impact of higher borrowing costs on home shoppers as the average rate on a 30-year mortgage more than doubled in recent years from ...

As major retailers and department stores continue closing, malls are looking for ways to boost foot traffic and sales.

Following a strong quarter leading up to the holidays, Wall Street analysts are anticipating Arkansas-based Walmart to post fourth-quarter earnings of 65 cents per share on $180 billion in sales.